Previous 10 | Next 10 |
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care® Clinical Reference Laboratory's FDA-authorized saliva-based PCR test uses technology developed by Co-Diagnostics to detect SARS-CoV...
Co-Diagnostics (NASDAQ: CODX) , considered a coronavirus stock because of its COVID-19 testing products, was up by nearly 9% in midafternoon trading on Wednesday. That's hardly surprising, since a major pharmacy chain announced today that a test using the company's technology is now...
Clinical Reference Laboratory Makes First At-Home COVID-19 Saliva Test Available Through Walgreens Find Care® The FDA-authorized, saliva-based COVID-19 RT-PCR test expands testing access with a comfortable, at-home alternative - eliminating in-person waits and reducing expo...
Tuesday was a busy day in the upper managerial ranks of Co-Diagnostics (NASDAQ: CODX) . The molecular diagnostics specialist appointed both a new CFO and a new chief science officer (CSO). The former is Brian Brown, who replaces current office holder Reed Benson. Brown has serve...
Co-Diagnostics, Inc. Announces New Chief Financial Officer Company also elevates in-house Senior VP of Biochemistry to Chief Scientific Officer PR Newswire SALT LAKE CITY , Feb. 23, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular dia...
Co-Diagnostics, Inc. to Present on Direct Saliva Testing Technology at Molecular Med Tri-Con Company believes direct saliva to play a key role in high throughput, point of care, and at home applications PR Newswire SALT LAKE CITY , Feb. 16, 2021 /PRNewswire/ ...
FN Media Group Presents USA News Group News Commentary Vancouver, BC – February 8, 2021 – USA News Group – As regulators in differing markets around the world continue to work on plans surrounding Covid-19 that will either open up their markets o...
Two of the most popular stocks on Robinhood's Top 100 list are TherapeuticsMD (NASDAQ: TXMD) and New Residential Investment (NYSE: NRZ) , both of which trade for under $10. The investment thesis for many excited investors is these stocks have a lot of room to grow. The probl...
The good news is that the end of the pandemic is in sight. The bad news is that it may never really be over. Even after we achieve the big goal of vaccine-induced herd immunity in the developed world, the pandemic will fester and mutate and hide out in the emerging world, continuously threate...
Co-Diagnostics (NASDAQ: CODX) was a penny stock at the beginning of 2020, with its shares trading hands for $0.90 at the beginning of the year. By December this biotech stock was up to $9.30. What caused this fantastic run-up, and is there any more gas in the tank? Motley Fool contr...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...